PhoenixBio Co., Ltd. (6190.T)
JPY 335.0
(-1.76%)
JPY 335.0
(-1.76%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 723.93 Million JPY | -35.93% |
| 2022 | 1.12 Billion JPY | 8.76% |
| 2021 | 1.03 Billion JPY | 0.02% |
| 2020 | 1.03 Billion JPY | -21.19% |
| 2019 | 1.31 Billion JPY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 459 Million JPY | -36.6% |
| 2023 Q4 | 723.93 Million JPY | 44.79% |
| 2023 Q3 | 500 Million JPY | -42.86% |
| 2023 Q1 | 875 Million JPY | -22.56% |
| 2023 Q2 | 875 Million JPY | 0.0% |
| 2023 FY | 723.93 Million JPY | -35.93% |
| 2022 Q3 | 875 Million JPY | -2.78% |
| 2022 Q2 | 900 Million JPY | 0.0% |
| 2022 Q4 | 1.12 Billion JPY | 29.14% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 2.46 Billion JPY | 70.687% |
| PRISM BioLab Co.,LTD | - JPY | -Infinity% |
| GNI Group Ltd. | 3.69 Billion JPY | 80.431% |
| Linical Co., Ltd. | 3 Billion JPY | 75.884% |
| Trans Genic Inc. | 2.25 Billion JPY | 67.926% |
| MEDINET Co., Ltd. | 2.3 Million JPY | -31279.757% |
| Soiken Holdings Inc. | - JPY | -Infinity% |
| Cytori Cell Research Institute, Inc. | 2.47 Billion JPY | 70.712% |
| AnGes, Inc. | 362.67 Million JPY | -99.609% |
| OncoTherapy Science, Inc. | 106.84 Million JPY | -577.527% |
| Nxera Pharma Co., Ltd. | 73.97 Billion JPY | 99.021% |
| Immuno-Biological Laboratories Co., Ltd. | 235.98 Million JPY | -206.774% |
| NanoCarrier Co., Ltd. | 1.1 Billion JPY | 34.717% |
| Carna Biosciences, Inc. | 182.97 Million JPY | -295.653% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 885.12 Million JPY | 18.211% |
| RaQualia Pharma Inc. | 367.71 Million JPY | -96.871% |
| Chiome Bioscience Inc. | 291 Million JPY | -148.774% |
| Kidswell Bio Corporation | 2.57 Billion JPY | 71.886% |
| PeptiDream Inc. | 22.79 Billion JPY | 96.825% |
| Oncolys BioPharma Inc. | 315.17 Million JPY | -129.695% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | 665 Million JPY | -8.862% |
| Healios K.K. | 4.53 Billion JPY | 84.026% |
| BrightPath Biotherapeutics Co., Ltd. | 112.5 Million JPY | -543.494% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 142.85 Million JPY | -406.766% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 97.54 Million JPY | -642.174% |
| FunPep Company Limited | - JPY | -Infinity% |
| Kringle Pharma, Inc. | - JPY | -Infinity% |
| Stella Pharma Corporation | 933.3 Million JPY | 22.433% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | - JPY | -Infinity% |
| Cuorips Inc. | - JPY | -Infinity% |
| K Pharma,Inc. | - JPY | -Infinity% |
| Takara Bio Inc. | 968 Million JPY | 25.214% |
| ReproCELL Incorporated | - JPY | -Infinity% |
| StemCell Institute Inc. | 8.78 Million JPY | -8141.473% |
| Japan Tissue Engineering Co., Ltd. | - JPY | -Infinity% |
| CellSeed Inc. | 151.25 Million JPY | -378.632% |